DrugCite
Search

MEDROL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Medrol Adverse Events Reported to the FDA Over Time

How are Medrol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Medrol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Medrol is flagged as the suspect drug causing the adverse event.

Most Common Medrol Adverse Events Reported to the FDA

What are the most common Medrol adverse events reported to the FDA?

Pyrexia
595 (1.1%)
Dyspnoea
532 (.98%)
Drug Ineffective
465 (.86%)
Cytomegalovirus Infection
384 (.71%)
Sepsis
375 (.69%)
Nausea
365 (.67%)
Headache
363 (.67%)
Pneumonia
348 (.64%)
Vomiting
330 (.61%)
Diarrhoea
325 (.6%)
Condition Aggravated
321 (.59%)
Show More Show More
Respiratory Failure
321 (.59%)
Thrombocytopenia
294 (.54%)
Multi-organ Failure
286 (.53%)
Hypertension
283 (.52%)
Asthenia
281 (.52%)
Anaemia
278 (.51%)
Malaise
263 (.48%)
Neutropenia
261 (.48%)
Pain
246 (.45%)
Abdominal Pain
243 (.45%)
Rash
239 (.44%)
Diabetes Mellitus
237 (.44%)
Renal Failure
233 (.43%)
Hypotension
229 (.42%)
Osteonecrosis
229 (.42%)
Erythema
227 (.42%)
Dizziness
225 (.41%)
Arthralgia
218 (.4%)
Hypersensitivity
211 (.39%)
Blood Pressure Increased
207 (.38%)
Interstitial Lung Disease
200 (.37%)
Fatigue
199 (.37%)
Pruritus
198 (.37%)
Depression
193 (.36%)
Urticaria
185 (.34%)
Renal Impairment
183 (.34%)
Septic Shock
183 (.34%)
Convulsion
180 (.33%)
Anxiety
179 (.33%)
Pain In Extremity
179 (.33%)
Back Pain
178 (.33%)
Drug Interaction
174 (.32%)
Kidney Transplant Rejection
173 (.32%)
Haemoglobin Decreased
168 (.31%)
Oedema Peripheral
165 (.3%)
Tachycardia
163 (.3%)
Blood Glucose Increased
162 (.3%)
Pneumocystis Jiroveci Pneumonia
162 (.3%)
Cardiac Arrest
160 (.3%)
General Physical Health Deteriorati...
160 (.3%)
Transplant Rejection
160 (.3%)
Blood Creatinine Increased
159 (.29%)
Tendon Rupture
158 (.29%)
Hyperglycaemia
157 (.29%)
Weight Decreased
156 (.29%)
Loss Of Consciousness
155 (.29%)
Weight Increased
155 (.29%)
Hypoaesthesia
154 (.28%)
Tremor
153 (.28%)
Chest Pain
151 (.28%)
Urinary Tract Infection
151 (.28%)
Confusional State
148 (.27%)
Pleural Effusion
148 (.27%)
Infection
147 (.27%)
Multiple Sclerosis Relapse
144 (.27%)
Anaphylactic Shock
143 (.26%)
Blood Pressure Decreased
143 (.26%)
Paraesthesia
143 (.26%)
Platelet Count Decreased
141 (.26%)
Muscular Weakness
139 (.26%)
Renal Failure Acute
138 (.25%)
Acute Respiratory Distress Syndrome
137 (.25%)
Pancytopenia
137 (.25%)
Atrial Fibrillation
136 (.25%)
Chills
136 (.25%)
Aspergillosis
134 (.25%)
Staphylococcal Infection
134 (.25%)
Gastrointestinal Haemorrhage
132 (.24%)
Insomnia
132 (.24%)
Aspartate Aminotransferase Increase...
131 (.24%)
Respiratory Distress
131 (.24%)
Tendonitis
130 (.24%)
Dehydration
128 (.24%)
Hyperhidrosis
128 (.24%)
Hepatic Function Abnormal
125 (.23%)
Gait Disturbance
124 (.23%)
Anaphylactic Reaction
123 (.23%)
Fall
121 (.22%)
Feeling Abnormal
121 (.22%)
Alanine Aminotransferase Increased
120 (.22%)
Drug Exposure During Pregnancy
120 (.22%)
Flushing
117 (.22%)
Drug Hypersensitivity
116 (.21%)
Haemodialysis
116 (.21%)
Rotator Cuff Syndrome
116 (.21%)
Death
115 (.21%)
Heart Rate Increased
115 (.21%)
Leukopenia
114 (.21%)
Peritonitis
113 (.21%)
Asthma
112 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Medrol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Medrol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Medrol

What are the most common Medrol adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Medrol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Medrol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Medrol According to Those Reporting Adverse Events

Why are people taking Medrol, according to those reporting adverse events to the FDA?

Rheumatoid Arthritis
1713
Premedication
1683
Drug Use For Unknown Indication
1290
Product Used For Unknown Indication
1088
Renal Transplant
920
Multiple Sclerosis
665
Show More Show More
Asthma
461
Immunosuppression
458
Prophylaxis
350
Prophylaxis Against Transplant Reje...
318
Prophylaxis Against Graft Versus Ho...
259
Multiple Sclerosis Relapse
256
Liver Transplant
253
Graft Versus Host Disease
232
Ill-defined Disorder
222
Crohns Disease
188
Interstitial Lung Disease
188
Systemic Lupus Erythematosus
179
Acute Lymphocytic Leukaemia
175
Chronic Obstructive Pulmonary Disea...
159
Arthritis
149
Pain
144
Inflammation
132
Immunosuppressant Drug Therapy
131
Back Pain
123
Non-hodgkins Lymphoma
118
Colitis Ulcerative
111
Nephrotic Syndrome
108
Lupus Nephritis
107
Juvenile Arthritis
104
Bronchitis
100
Pneumonia
98
Rash
97
Hypersensitivity
95
Dermatomyositis
94
Transplant Rejection
86
Lymphoma
80
Arthralgia
80
Multiple Myeloma
79
Chronic Lymphocytic Leukaemia
76
Sinusitis
74
Lung Transplant
74
Prophylaxis Of Nausea And Vomiting
68
Psoriatic Arthropathy
66
Aplastic Anaemia
65
Breast Cancer Metastatic
65
Acute Graft Versus Host Disease
64
Vasculitis
62
Ankylosing Spondylitis
61
Wegeners Granulomatosis
60
Diffuse Large B-cell Lymphoma
59

Drug Labels

LabelLabelerEffective
Depo-medrolPharmacia and Upjohn Company30-MAR-10
Medrol Stat Rx USA01-APR-10
Depo-medrolPharmacia and Upjohn Company19-APR-10
Depo-medrolPhysicians Total Care, Inc.20-APR-10
Depo-medrolPharmacia and Upjohn Company20-APR-10
Depo-medrolPharmacia and Upjohn Company20-APR-10
MedrolPharmacia and Upjohn Company27-APR-10
Solu-medrolGeneral Injectables & Vaccines, Inc01-SEP-10
Solu-medrolGeneral Injectables & Vaccines, Inc09-SEP-10
Depo-medrolRebel Distributors Corp28-JUN-11
MedrolREMEDYREPACK INC. 11-OCT-11
Solu-medrolREMEDYREPACK INC. 19-DEC-11
Depo-medrolDispensing Solutions, Inc.01-FEB-12
Solu-medrolCardinal Health03-MAY-12
Solu-medrolPharmacia and Upjohn Company01-JUN-12
Solu-medrolPharmacia and Upjohn Company01-JUN-12
Solu-medrolPharmacia and Upjohn Company02-JUL-12
Solu-medrolCardinal Health13-JUL-12
Depo-medrolCardinal Health06-AUG-12
Solu-medrolGeneral Injectables & Vaccines, Inc14-DEC-12
Solu-medrolGeneral Injectables & Vaccines, Inc26-DEC-12
Solu-medrolREMEDYREPACK INC. 09-FEB-13
MedrolREMEDYREPACK INC. 19-FEB-13
Solu-medrolCardinal Health20-MAR-13
Solu-medrolCardinal Health04-APR-13
Depo-medrolREMEDYREPACK INC. 10-APR-13
Solu-medrolREMEDYREPACK INC. 15-APR-13
MedrolPharmacia and Upjohn Company17-APR-13
Depo-medrolPharmacia and Upjohn Company24-APR-13

Medrol Case Reports

What Medrol safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Medrol. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Medrol.